||Compliance with anti-tuberculosis chemotherapy in developing
||TUBERCLE 1987, 68, 19-24.
The paper discusses various aspects of compliance
with anti-TB chemotherapy in developing countries. The problem of
definition of compliance in a developing-country context, the classification
and consequences of non-compliance and the entity (ies) responsible
for compliance are elaborated. A description of the direct methods
(several biological methods such as qualitative urine tests revealing
the presence of isoniazid metabolites a day after drug is taken)
and indirect methods of evaluating compliance such as monitoring
patient attendance at the dates appointed for drug administration
or receipt of drugs, is presented. Several steps are recommended
to be taken to improve compliance in developing nations.
|KEYWORDS: COMPLIANCE; ALGERIA.